Since vimentin is over expressed during EMT process, and NF-κB being one of the transcription factors binding to vimentin promoter, it would be tempting to speculate that this over-expression of vimentin is a result of activated NF-κB in cancer cells. This evidence concerns the gene NFKB1 and cancer.